Rozpowszechnienie epilepsji i obciążenie schorzeniami podstawowymi: kanadyjska walidacja szacunków duńskich
PubMed➕ 09.10.2026Epilepsia
Prevalence of epilepsy and the burden of underlying causes: Canadian validation of Danish estimates
W skrócie
Badacze sprawdzili, czy wyniki duńskiego badania dotyczące epilepsji wtórnej (spowodowanej innym schorzeniem) dotyczą również Kanady. Przeanalizowali ponad 4 miliony mieszkańców Alberty i znaleźli, że epilepsja wtórna, zwłaszcza wynikająca z udarów mózgu i otępienia, staje się coraz bardziej powszechna wraz z wiekiem, podczas gdy epilepsja pierwotna (bez widocznej przyczyny) dominuje w młodszych latach. Wyniki potwierdzają, że przyczyny epilepsji zmieniają się w zależności od wieku i zależą od tego, jak dokładnie je definiujemy w bazach danych medycznych.
Oryginalny abstract (angielski)
OBJECTIVE: Recent work has provided population-based estimates of the prevalence of cause-specific epilepsy across the lifespan in Denmark. We sought to externally validate these Danish "secondary epilepsy" findings to ascertain consistency across geographic regions. METHODS: We conducted a population-based cross-sectional study using linked Alberta Health Care Insurance Plan administrative datasets. Epilepsy was identified using a validated algorithm. Point prevalence was calculated on December 31, 2018 among residents alive at that date. Secondary epilepsy was assigned when a recognized antecedent condition (stroke, traumatic brain injury [TBI], dementia, brain neoplasm, congenital brain malformations/perinatal conditions, or central nervous system infection) occurred before the first epilepsy diagnosis. If no antecedent condition was identified, the case was classified as "idiopathic." In sensitivity analyses, Danish-derived definitions were replaced with published validated case definitions. RESULTS: Among ~4.274 million Albertans, 26 056 prevalent epilepsy cases were identified (606 per 100 000; 584 females, 628 males). Idiopathic epilepsy accounted for 394 per 100 000 and secondary epilepsy for 212 per 100 000. Prevalence peaked in childhood, stabilized by early adulthood, and then increased after age 40 years, where male cases exceeded females. The proportional contribution of idiopathic epilepsy declined after midlife, with secondary epilepsy predominating by ages 65-70 years. Cause-specific patterns were largely consistent with Denmark, exhibiting age-dependency: congenital/perinatal causes in youth, TBI most common in young/middle-aged adults, and stroke and dementia in older adults. Use of published validated definitions reduced secondary epilepsy prevalence to 139 per 100 000 and increased idiopathic prevalence to 467 per 100 000, largely driven by fewer cases attributed to stroke. SIGNIFICANCE: Secondary epilepsy becomes increasingly dominant with age, but cause-specific attribution is sensitive to administrative case definitions. This highlights the need for rigorous and consistent algorithms to improve burden modeling, surveillance, and health-system planning. These analyses validate the Danish estimates and inform future work deriving regional cause-specific epilepsy burden.
Metadane publikacji
Journal
Epilepsia
Data publikacji
08.10.2026
PMID
42847549
DOI
10.1002/epi.70494
Autorzy
Anderson M, Christensen J, Buxbaum C, Steinmetz J, Jette N, Wiebe S, Josephson CB
Słowa kluczowe
ICD‐10‐CA, administrative health data, epidemiology, epilepsy, prevalence